Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

被引：28
|
作者：
Huiberts, Anne J. [1 ]
de Gier, Brechje [1 ]
Hoeve, Christina E. [1 ]
de Melker, Hester E. [1 ]
Hahne, Susan J. M. [1 ]
den Hartog, Gerco [1 ,2 ]
van de Wijgert, Janneke H. H. M. [1 ,3 ]
van den Hof, Susan [1 ]
Knol, Mirjam J. [1 ]
机构：
[1] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
[2] Radboudumc, Radboud Ctr Infect Dis, Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
EUROSURVEILLANCE | 2023年 / 28卷 / 07期
关键词：
D O I：
10.2807/1560-7917.ES.2023.28.7.2300087
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We used data of 32,542 prospective cohort study participants who previously received primary and one or two monovalent booster COVID-19 vaccinations. Between 26 September and 19 December 2022, relative effectiveness of bivalent original/Omicron BA.1 vaccination against self-reported Omicron SARS-CoV-2 infection was 31% in 18- 59-year-olds and 14% in 60- 85-year-olds. Protection of Omicron infection was higher than of bivalent vaccination without prior infection. Although bivalent booster vaccination increases protection against COVID- 19 hospitalisations, we found limited added benefit in preventing SARS-CoV-2 infection.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
    Vasin, Andrey V.
    Stukova, Marina A.
    LANCET INFECTIOUS DISEASES, 2023, 23 (08): : 880 - 881
  • [2] Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
    Widyasari, Kristin
    Jang, Jieun
    Kang, Taejoon
    Kim, Sunjoo
    VIRUSES-BASEL, 2023, 15 (08):
  • [3] mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
    Nanishi, Etsuro
    McGrath, Marisa E.
    O'Meara, Timothy R.
    Barman, Soumik
    Yu, Jingyou
    Wan, Huahua
    Dillen, Carly A.
    Menon, Manisha
    Seo, Hyuk-Soo
    Song, Kijun
    Xu, Andrew Z.
    Sebastian, Luke
    Brook, Byron
    Bosco, Anna-Nicole
    Borriello, Francesco
    Ernst, Robert K.
    Barouch, Dan H.
    Dhe-Paganon, Sirano
    Levy, Ofer
    Frieman, Matthew B.
    Dowling, David J.
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [4] Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
    Zhenhao Fang
    Lei Peng
    Renata Filler
    Kazushi Suzuki
    Andrew McNamara
    Qianqian Lin
    Paul A. Renauer
    Luojia Yang
    Bridget Menasche
    Angie Sanchez
    Ping Ren
    Qiancheng Xiong
    Madison Strine
    Paul Clark
    Chenxiang Lin
    Albert I. Ko
    Nathan D. Grubaugh
    Craig B. Wilen
    Sidi Chen
    Nature Communications, 13
  • [5] Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
    Fang, Zhenhao
    Peng, Lei
    Filler, Renata
    Suzuki, Kazushi
    McNamara, Andrew
    Lin, Qianqian
    Renauer, Paul A.
    Yang, Luojia
    Menasche, Bridget
    Sanchez, Angie
    Ren, Ping
    Xiong, Qiancheng
    Strine, Madison
    Clark, Paul
    Lin, Chenxiang
    Ko, Albert, I
    Grubaugh, Nathan D.
    Wilen, Craig B.
    Chen, Sidi
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [6] mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
    Etsuro Nanishi
    Marisa E. McGrath
    Timothy R. O’Meara
    Soumik Barman
    Jingyou Yu
    Huahua Wan
    Carly A. Dillen
    Manisha Menon
    Hyuk-Soo Seo
    Kijun Song
    Andrew Z. Xu
    Luke Sebastian
    Byron Brook
    Anna-Nicole Bosco
    Francesco Borriello
    Robert K. Ernst
    Dan H. Barouch
    Sirano Dhe-Paganon
    Ofer Levy
    Matthew B. Frieman
    David J. Dowling
    Communications Biology, 5
  • [7] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Hu, Yuehong
    Sun, Qiu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [8] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Yuehong Hu
    Qiu Sun
    Signal Transduction and Targeted Therapy, 7
  • [9] SARS-CoV-2 neutralising antibody response to bivalent booster after omicron infection
    Springer, David N.
    Medits, Iris
    Weseslindtner, Lukas
    Stiasny, Karin
    Aberle, Judith H.
    LANCET MICROBE, 2024, 5 (01): : E8 - E8
  • [10] Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    AlMukdad, Sawsan
    Faust, Jeremy S.
    Tang, Patrick
    Coyle, Peter
    Yassine, Hadi M.
    Al Thani, Asmaa A.
    Al-Khatib, Hebah A.
    Hasan, Mohammad R.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar H.
    Latif, Ali N.
    Shaik, Riyazuddin M.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed G.
    Butt, Adeel A.
    Al-Romaihi, Hamad E.
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Abu-Raddad, Laith J.
    JOURNAL OF TRAVEL MEDICINE, 2023, 30 (05)
12345